Valuation: Avantor, Inc.

Market Cap 7.28B 6.38B 5.9B 5.42B 10.24B 702B 10.4B 70.49B 27.62B 343B 27.33B 26.73B 1,183B P/E 2026 *
28.8x
P/E 2027 * 24.7x
Enterprise Value 10.29B 9.02B 8.34B 7.66B 14.48B 992B 14.7B 99.67B 39.05B 486B 38.64B 37.79B 1,672B EV / Sales 2026 *
1.58x
EV / Sales 2027 * 1.45x
Free-Float
95.54%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 56 17/08/2025
Director of Finance/CFO 50 23/06/2026
Chief Operating Officer - 09/11/2025
Director TitleAgeSince
Director/Board Member 60 21/04/2020
Chairman 69 31/12/2025
Director/Board Member 62 30/09/2021
Change 5-day change 1-year change 3-year change Capi.($)
+0.84%-2.93% - - 7.56B
+0.97%+8.23%-17.80%-5.24% 175B
+0.11%-0.69%-7.05%-3.29% 106B
-1.27%+0.18%+3.80%+58.38% 59.91B
+0.66%+0.96%+37.64%+54.22% 51.95B
-2.33%+1.67%-13.63%-39.40% 43.58B
-2.29%-5.26% - - 33.65B
-1.25%+0.97%-9.77%-43.36% 29.58B
-1.65%-0.39%+67.06%-8.64% 25.31B
-1.55%-0.71%-4.93%-5.70% 21.23B
Average -0.78%+1.58%+6.92%+0.87% 60.79B
Weighted average by Cap. -0.26%+2.75%-1.91%+3.32%

Financials

2026 *2027 *
Net sales 6.5B 5.7B 5.27B 4.84B 9.15B 627B 9.29B 62.96B 24.66B 307B 24.41B 23.87B 1,056B 6.64B 5.82B 5.38B 4.94B 9.34B 640B 9.48B 64.28B 25.18B 313B 24.92B 24.38B 1,078B
Net income 244M 214M 198M 182M 343M 23.52B 348M 2.36B 925M 11.51B 916M 896M 39.63B 289M 253M 234M 215M 407M 27.87B 413M 2.8B 1.1B 13.64B 1.09B 1.06B 46.96B
Net Debt 3.01B 2.64B 2.44B 2.24B 4.24B 290B 4.3B 29.17B 11.43B 142B 11.31B 11.06B 489B 2.36B 2.07B 1.91B 1.76B 3.33B 228B 3.38B 22.88B 8.96B 111B 8.87B 8.68B 384B
Logo Avantor, Inc.
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Employees
13,500
Trader
Investor
Global
Quality
ESG MSCI
-